Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Metastasis02:30

Metastasis

6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.

EClinicalMedicine·2026
Same author

Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trial.

Journal of neurosurgery. Pediatrics·2026
Same author

Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all Ages.

Neuro-oncology·2026
Same author

<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma.

bioRxiv : the preprint server for biology·2026
Same author

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.

The Lancet. Child & adolescent health·2026
Same author

Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-'87/'92 studies.

Neuro-oncology practice·2026

Related Experiment Video

Updated: Dec 17, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.5K

ETMR: a tumor entity in its infancy.

Sander Lambo1,2, Katja von Hoff3, Andrey Korshunov4,5

  • 1Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.

Acta Neuropathologica
|July 1, 2020
PubMed
Summary
This summary is machine-generated.

Embryonal tumor with multilayered rosettes (ETMR) is a rare infant brain tumor. Despite molecular insights, survival rates remain low, highlighting the urgent need for effective targeted therapies.

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 17, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.0K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.0K

Area of Science:

  • Pediatric neuro-oncology
  • Molecular diagnostics
  • Genomic alterations in brain tumors

Background:

  • Embryonal tumor with multilayered rosettes (ETMR) is a rare, aggressive pediatric brain tumor.
  • Advances in molecular diagnostics, including C19MC amplification and LIN28A expression, have improved ETMR identification.
  • Despite improved understanding, treatment outcomes for ETMR remain poor, with low survival rates.

Purpose of the Study:

  • To provide a comprehensive overview of the clinical and molecular characteristics of ETMR.
  • To review current progress and potential targeted therapies for ETMR.
  • To address the urgent need for improved treatment strategies for this deadly brain tumor.

Main Methods:

  • Review of clinical data and molecular landscape of ETMR.
  • Analysis of genetic aberrations, including C19MC amplification and DICER1 mutations.
  • Evaluation of downstream pathways affected by miRNA deregulation and potential therapeutic targets.

Main Results:

  • ETMRs are characterized by C19MC amplification or DICER1 mutations, impacting miRNA pathways.
  • LIN28A is a consistent diagnostic marker across heterogeneous ETMR histology.
  • Proposed therapeutic vulnerabilities include targeting WNT, SHH, mTOR pathways, MYCN, or chromosomal instability.

Conclusions:

  • Significant progress has been made in understanding ETMR molecular biology.
  • Current treatment outcomes remain dismal, necessitating translation of research into effective therapies.
  • Targeted therapies hold promise but require further development and clinical validation for ETMR.